These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35394718)

  • 21. Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis.
    Bruyere O; Reginster JY
    Drugs Aging; 2007; 24(7):573-80. PubMed ID: 17658908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined Treatment With Chondroitin Sulfate and Glucosamine Sulfate Shows No Superiority Over Placebo for Reduction of Joint Pain and Functional Impairment in Patients With Knee Osteoarthritis: A Six-Month Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Roman-Blas JA; Castañeda S; Sánchez-Pernaute O; Largo R; Herrero-Beaumont G;
    Arthritis Rheumatol; 2017 Jan; 69(1):77-85. PubMed ID: 27477804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A potential role for avocado- and soybean-based nutritional supplements in the management of osteoarthritis: a review.
    DiNubile NA
    Phys Sportsmed; 2010 Jun; 38(2):71-81. PubMed ID: 20631466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The place of chondroitin sulfate and glucosamine sulfate in osteoarthritis pain therapy: a practical view from evidence-based medicine].
    Naumov AV; Khovasova NO; Moroz VI; Tkacheva ON
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9):112-117. PubMed ID: 31626227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Glucosamine-Chondroitin Sulfate with and without Methylsulfonylmethane in Grade I-II Knee Osteoarthritis: A Double Blind Randomized Controlled Trial.
    Lubis AMT; Siagian C; Wonggokusuma E; Marsetyo AF; Setyohadi B
    Acta Med Indones; 2017 Apr; 49(2):105-111. PubMed ID: 28790224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis?
    Henrotin Y; Marty M; Mobasheri A
    Maturitas; 2014 Jul; 78(3):184-7. PubMed ID: 24861964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of knee osteoarthritis with a new formulation of a fixed-dose combination of glucosamine sulfate and bovine chondroitin: a multicenter, randomized, single-blind, non-inferiority clinical trial.
    Lomonte ABV; Gimenez E; da Silva AC; Radominski SC; Scheinberg MA; Ximenes AC; de Freitas Zerbini CA
    Adv Rheumatol; 2021 Jan; 61(1):7. PubMed ID: 33468249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of Symptomatic Slow-Acting Drugs for Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis.
    Honvo G; Reginster JY; Rabenda V; Geerinck A; Mkinsi O; Charles A; Rizzoli R; Cooper C; Avouac B; Bruyère O
    Drugs Aging; 2019 Apr; 36(Suppl 1):65-99. PubMed ID: 31073924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chondroitin sulphate: a focus on osteoarthritis.
    Bishnoi M; Jain A; Hurkat P; Jain SK
    Glycoconj J; 2016 Oct; 33(5):693-705. PubMed ID: 27194526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate.
    Deal CL; Moskowitz RW
    Rheum Dis Clin North Am; 1999 May; 25(2):379-95. PubMed ID: 10356424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy Treatment of Osteoarthritis with Combine Chondroitin and Glucosamine.
    Materkowski M
    Ortop Traumatol Rehabil; 2021 Jun; 23(3):239-244. PubMed ID: 34190047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chondroitin for osteoarthritis.
    Singh JA; Noorbaloochi S; MacDonald R; Maxwell LJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD005614. PubMed ID: 25629804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of glucosamine for knee osteoarthritis: why patented crystalline glucosamine sulfate should be differentiated from other glucosamines to maximize clinical outcomes.
    Kucharz EJ; Kovalenko V; Szántó S; Bruyère O; Cooper C; Reginster JY
    Curr Med Res Opin; 2016 Jun; 32(6):997-1004. PubMed ID: 26881468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacological treatment of osteoarthritis. Expectations and reality].
    Mulero Mendoza J
    Rev Clin Esp; 2005 Apr; 205(4):168-71. PubMed ID: 15860188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on the role of pharmaceutical-grade chondroitin sulfate in the symptomatic management of knee osteoarthritis.
    Honvo G; Bruyère O; Reginster JY
    Aging Clin Exp Res; 2019 Aug; 31(8):1163-1167. PubMed ID: 31243744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intra-articular viscosupplementation with hylan g-f 20 to treat osteoarthritis of the knee: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(10):1-66. PubMed ID: 23074461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chondroitin sulfate and glucosamine sulfate associated to photobiomodulation prevents degenerative morphological changes in an experimental model of osteoarthritis in rats.
    Sanches M; Assis L; Criniti C; Fernandes D; Tim C; Renno ACM
    Lasers Med Sci; 2018 Apr; 33(3):549-557. PubMed ID: 29196833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of various SYSADOA for the osteoarthritis treatment: an experimental study in rabbits.
    Permuy M; Guede D; López-Peña M; Muñoz F; Caeiro JR; González-Cantalapiedra A
    BMC Musculoskelet Disord; 2015 May; 16():120. PubMed ID: 25986068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Pharmacological Treatments With Long-term Pain Control in Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis.
    Gregori D; Giacovelli G; Minto C; Barbetta B; Gualtieri F; Azzolina D; Vaghi P; Rovati LC
    JAMA; 2018 Dec; 320(24):2564-2579. PubMed ID: 30575881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-surgical management of knee osteoarthritis: comparison of ESCEO and OARSI 2019 guidelines.
    Arden NK; Perry TA; Bannuru RR; Bruyère O; Cooper C; Haugen IK; Hochberg MC; McAlindon TE; Mobasheri A; Reginster JY
    Nat Rev Rheumatol; 2021 Jan; 17(1):59-66. PubMed ID: 33116279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.